Cortisol DHEA Ratio Biomarker Research

---

Table of Contents

1. What Is the Cortisol/DHEA Ratio?
2. Why Researchers Study This Ratio as a Biomarker
3. The Biology Behind the Balance
4. What Recent Research Says: 2024–2026 Findings
5. Cortisol DHEA Ratio and Aging: A Closer Look
6. Stress, Burnout, and Mental Health Applications
7. Testing Methods: Saliva, Blood, or Hair?
8. What Are Normal or Optimal Ranges?
9. How Reliable Is the Ratio Compared to Cortisol Alone?
10. Is There Enough Evidence for Clinical Use?
11. Key Takeaways for Clinicians and Researchers
12. Frequently Asked Questions

---

Introduction

Open any functional medicine panel, integrative health protocol, or adrenal stress report and you will almost certainly encounter the cortisol DHEA ratio biomarker research debate. Proponents argue that measuring the balance between cortisol and dehydroepiandrosterone (DHEA or its sulfated form, DHEA-S) captures something fundamentally important about how the adrenal glands respond to chronic load, immune regulation, and biological aging. Critics point out that standardization is poor, reference ranges vary widely, and the clinical evidence base remains thin.

Who is right? The honest answer in 2026 is: both camps have valid points.

This post synthesizes the most current peer-reviewed data — including studies published between 2024 and 2026 — to give clinicians, researchers, and informed readers a complete, evidence-graded picture of what the cortisol/DHEA ratio does and does not tell us. We cover the underlying physiology, specimen-specific findings, aging research, stress applications, and the ongoing debate about clinical readiness.

---

What Is the Cortisol/DHEA Ratio?

The DHEA cortisol ratio — sometimes written as the cortisol-to-DHEA or cortisol-to-DHEA-S ratio — is a derived biomarker calculated by dividing a cortisol measurement by a simultaneous DHEA or DHEA-sulfate measurement collected from the same biological specimen (saliva, serum, urine, or scalp hair).

The Two Hormones Involved

Cortisol is the primary glucocorticoid secreted by the zona fasciculata of the adrenal cortex. It is released in a diurnal rhythm, spiking shortly after waking (the cortisol awakening response), and is acutely elevated during psychological or physiological stress through activation of the hypothalamic-pituitary-adrenal (HPA) axis.

DHEA is an androgen precursor produced primarily in the zona reticularis of the adrenal cortex, with secondary contributions from the gonads and brain. Most circulating DHEA is rapidly sulfated to DHEA-S (dehydroepiandrosterone sulfate) in the adrenal gland and liver. DHEA-S has a much longer half-life than cortisol — measured in hours rather than minutes — which makes it a more stable analyte for certain testing formats.

Why a Ratio Rather Than Absolute Values?

In isolation, cortisol and DHEA each convey partial information. Cortisol is highly pulsatile and context-dependent; a single measurement can reflect acute stress, time of day, poor sleep the night before, or laboratory collection anxiety. DHEA and DHEA-S decline progressively with age (a process called adrenopause), so absolute values must always be interpreted against age-adjusted references.

The ratio attempts to capture something about the relative balance between these two adrenal outputs — specifically, whether catabolic/inflammatory signaling (represented loosely by cortisol) is disproportionately elevated relative to anabolic/neuroprotective signaling (represented loosely by DHEA). The hypothesis is that cortisol DHEA health is best understood as a dynamic equilibrium, not as two independent measurements.

---

Why Researchers Study This Ratio as a Biomarker

The intellectual case for studying the DHEA cortisol ratio as a standalone biomarker rests on several converging observations:

1. Opposite Physiological Actions

Cortisol and DHEA exert broadly antagonistic effects across multiple organ systems:

• Immune function: Cortisol is immunosuppressive at high concentrations; DHEA has immunostimulatory and anti-inflammatory properties, particularly through modulation of IL-6 and TNF-α pathways.
• Neuroprotection: DHEA and its neurosteroid derivatives (DHEA-S, androstenediol) are associated with GABA-A receptor modulation and NMDA receptor activity. Chronically elevated cortisol is associated with hippocampal volume loss; DHEA may partially counteract this effect.
• Metabolic effects: Cortisol promotes gluconeogenesis, insulin resistance, and visceral adiposity; DHEA has been linked to improved insulin sensitivity and favorable lipid profiles in some populations.
• Bone and muscle: Prolonged cortisol excess promotes catabolism; DHEA serves as a precursor to anabolic sex steroids.

2. Divergent Trajectories with Age

Perhaps the most compelling reason to track the cortisol DHEA aging relationship is the pronounced divergence between these two hormones across the lifespan. Cortisol levels remain relatively stable or modestly increase with age, while DHEA-S peaks in the mid-20s and declines at approximately 2–3% per year thereafter. By age 70–80, DHEA-S levels may be only 10–20% of peak values. The result is a progressively rising cortisol/DHEA-S ratio with age — an endocrine shift that many researchers believe contributes to the pathophysiology of aging and age-related diseases.

3. The Allostatic Load Framework

Within the broader concept of allostatic load — the cumulative biological cost of chronic stress — the cortisol/DHEA ratio is proposed as a single composite index that captures adrenal imbalance more sensitively than cortisol alone. This framing is particularly influential in research on occupational burnout, post-traumatic stress disorder (PTSD), and early-life adversity.

4. Epigenetic and Oxidative Stress Connections

More recent cortisol DHEA biomarker research has extended into epigenomics. If the ratio reflects something real about biological aging, it should correlate with epigenetic clock measures — a prediction that 2025 research has now tested directly (discussed in detail below).

---

The Biology Behind the Balance

Understanding DHEA-S cortisol balance requires a brief tour of adrenal steroidogenesis.

Shared Precursor, Divergent Pathways

Both cortisol and DHEA originate from cholesterol via pregnenolone. The critical branch point occurs at 17-hydroxypregnenolone:

• The Δ5 pathway (catalyzed by CYP17A1 17,20-lyase activity) leads to DHEA and ultimately DHEA-S.
• The Δ4 pathway (cortisol biosynthesis) proceeds through 17-hydroxyprogesterone, 11-deoxycortisol, and finally cortisol via CYP11B1.

Importantly, ACTH (adrenocorticotropic hormone) stimulates both pathways. However, with chronic HPA axis activation, there appears to be preferential upregulation of the cortisol pathway relative to the DHEA pathway. The mechanisms are not fully understood but may involve relative changes in CYP17A1 17,20-lyase activity, intra-adrenal paracrine signaling, and zona reticularis atrophy seen in chronic stress states.

DHEA-S: The Stable Storage Form

DHEA is rapidly sulfated to DHEA-S by the enzyme SULT2A1, primarily in the adrenal cortex and liver. DHEA-S has a half-life of 7–10 hours compared to cortisol's 60–90 minutes. This means:

• DHEA-S is less sensitive to acute stressors and more reflective of chronic adrenal output
• DHEA-S is the preferred analyte in blood and dried blood spot testing
• In salivary testing, unconjugated DHEA is more commonly measured because DHEA-S does not readily enter saliva via passive diffusion

This distinction matters enormously when interpreting cortisol DHEA ratio research: studies using salivary DHEA and studies using serum DHEA-S are not directly equivalent, and their reference ranges cannot be freely interchanged.

Neurosteroid Contributions

A biologically important nuance is that DHEA is also synthesized de novo in the brain (earning it the label "neurosteroid"), independent of adrenal production. Central DHEA synthesis may follow different regulatory rules than adrenal production. Some cortisol DHEA clinical researchers argue this distinction is particularly relevant for psychiatric and neurodegenerative applications, where brain DHEA may buffer glucocorticoid neurotoxicity even when peripheral DHEA-S is depleted.

---

What Recent Research Says: 2024–2026 Findings

The past two years have produced a cluster of rigorous studies that significantly sharpen — and in some cases complicate — the picture of what the cortisol DHEA ratio research field has established.

2024: Hair Cortisol/DHEA as a Chronic Stress Marker — Insufficient Evidence

A 2024 systematic review and meta-analysis (indexed on PubMed, PMID 40978330) specifically examined the hair cortisol/DHEA ratio as a potential chronic stress biomarker — one of the most clinically appealing applications, since scalp hair theoretically captures a retrospective window of 1–3 months of integrated hormone output.

The findings were sobering. Pooling data from two studies that used validated stress scales, the DHEA cortisol balance research review found:

• No significant association between the hair cortisol/DHEA ratio and perceived stress (ρ = 0.09, 95% CI −0.07 to 0.26, I² = 0%)
• The confidence interval was narrow enough to rule out a large effect, but the point estimate was positive — meaning a very small positive relationship cannot be excluded
• The authors explicitly concluded that the evidence was insufficient for clinical application and called for standardized longitudinal studies

This is a critical finding for practitioners who order hair hormone panels as chronic stress assessments. The meta-analytic evidence does not currently support the hair cortisol/DHEA ratio as a validated chronic stress biomarker.

2024: Early-Life Stress, Boys, and Externalizing Problems

A 2024 study published in a peer-reviewed psychoneuroendocrinology journal examined whether the DHEA cortisol ratio mediates the association between early-life stress and externalizing behavioral problems in adolescents.

Key finding: A lower cortisol/DHEA ratio mediated the relationship between early-life stress exposure and externalizing problems specifically in boys. This is notable for several reasons:

1. It is a sex-specific effect — not observed in girls, suggesting sex hormones or sex-linked HPA axis programming may modulate the relationship
2. The direction is counterintuitive relative to the "high ratio = bad" narrative: here, a lower ratio was associated with worse outcomes, possibly reflecting blunted cortisol response or elevated DHEA-driven arousal
3. It raises the possibility that the cortisol/DHEA ratio operates differently across developmental stages than in adults

2024: Acute Academic Stress and the Ratio

A study published in Neuro Endocrinology Letters in 2024 examined how salivary cortisol and the cortisol/DHEA ratio changed in students before and after a major examination.

Results:

• Both salivary cortisol and the cortisol/DHEA ratio were significantly higher pre-examination compared to a non-stress control period
• The post-examination cortisol/DHEA ratio correlated moderately with academic performance (Spearman's rs = 0.44, p = 0.039)
• This correlation was stronger for the ratio than for cortisol alone

This study suggests the cortisol DHEA ratio is responsive to acute psychosocial stress and may carry performance-related information beyond what cortisol alone provides. However, a single-group observational design limits causal inference.

2025: The Epigenetic Aging Study

The most methodologically sophisticated recent contribution to cortisol DHEA ratio research is a 2025 study (published August 16, 2025, available at PMC12357812) that examined whether cortisol, DHEA-S, and the cortisol/DHEA-S ratio predict epigenetic age acceleration beyond chronological age.

Key findings:

• Cortisol and the cortisol/DHEA-S ratio explained only 0.5%–1.1% of additional variance in epigenetic clock measures beyond what chronological age alone explained
• However, the cortisol/DHEAS ratio was the only hormonal measure significantly correlated with epigenetic age acceleration for the Hannum epigenetic clock
• This association was not significant for the Horvath clock or other tested epigenetic clocks, suggesting clock-specific sensitivity

The interpretation is nuanced: on one hand, the effect size is small — these hormonal measures are not strong predictors of epigenetic aging. On the other hand, achieving statistical significance while explaining incremental variance beyond chronological age is a meaningful result, since epigenetic clocks are already quite sensitive to age-related biological variation.

2025–2026: Oxidative Stress Connections in Korean Adults

An indexed study examining the relationship between cortisol, DHEA-S, the cortisol/DHEA-S ratio, and oxidative stress markers in Korean adults adds another dimension to the DHEA cortisol aging health literature. This study connects adrenal hormone balance to reactive oxygen species pathways — a biologically plausible link given that glucocorticoid excess is known to promote mitochondrial dysfunction and oxidative stress, while DHEA has demonstrated antioxidant properties in cell culture and animal models.

The inclusion of oxidative stress markers in DHEA cortisol clinical research is methodologically important because it provides potential mechanistic intermediaries between adrenal imbalance and downstream health outcomes.

---

Cortisol DHEA Ratio and Aging: A Closer Look

The cortisol DHEA aging relationship is arguably the most studied application of this biomarker, and the foundational cohort data remain compelling even if newer molecular findings add complexity.

The 2010 Mortality Cohort Study

A landmark 2010 cohort study demonstrated that a higher cortisol:DHEA-S ratio was associated with greater risk of all-cause mortality, cancer mortality, and death from other medical causes. This study is frequently cited in DHEA cortisol aging health discussions because it used a prospective design with hard outcomes — not just surrogate biomarkers.

The mortality finding is consistent with the known biology: progressive DHEA-S decline combined with relatively preserved or elevated cortisol creates a hormonal milieu associated with increased inflammation, impaired immune surveillance (potentially relevant to cancer risk), metabolic dysregulation, and reduced cellular stress resistance.

Adrenopause and the Rising Ratio

The concept of adrenopause — the age-related decline in adrenal androgen production — explains much of the longitudinal trajectory of the DHEA cortisol aging ratio. The clinical implications include:

• Immune senescence: The immunostimulatory effects of DHEA diminish as DHEA-S falls, potentially contributing to reduced vaccine responsiveness, increased susceptibility to infection, and impaired tumor surveillance in older adults
• Neurological vulnerability: Reduced neurosteroid DHEA may decrease the brain's buffering capacity against glucocorticoid-induced hippocampal damage, relevant to age-associated memory decline
• Sarcopenia and frailty: The loss of DHEA as an androgen precursor reduces anabolic hormone availability, contributing to age-related muscle loss
• Psychological resilience: Several studies associate higher DHEA-S levels — and lower cortisol/DHEA-S ratios — with better coping, lower depression risk, and greater psychological resilience in aging populations

What the Epigenetic Clocks Add

The 2025 epigenetic aging study adds a molecular layer to this narrative. The fact that the cortisol/DHEA-S ratio specifically correlated with Hannum clock acceleration — even if modestly — suggests that the adrenal hormone balance leaves a detectable epigenetic signature. The Hannum clock is particularly sensitive to immune cell aging, which aligns with the immunological mechanisms described above.

The small effect size (0.5%–1.1% additional explained variance) means the ratio is not a dominant driver of epigenetic aging, but it may be one of many contributing factors within a broader allostatic load framework.

Is DHEA Supplementation the Answer?

A natural follow-up question for the cortisol DHEA health field is whether restoring DHEA-S through supplementation reverses the unfavorable ratio and its consequences. The evidence here is mixed:

• Randomized controlled trials of DHEA supplementation in older adults have shown modest improvements in bone density, libido, and some quality-of-life measures
• Effects on cognition, cardiovascular risk, and longevity are inconsistent across trials
• DHEA is a hormone precursor and its conversion profile varies by individual sex, genetics, and tissue-specific enzyme expression — meaning exogenous DHEA does not produce predictable hormonal outcomes in all individuals

The supplementation literature is outside the primary scope of this biomarker science post, but it underscores that simply identifying an unfavorable ratio does not automatically translate into a clear therapeutic intervention.

---

Stress, Burnout, and Mental Health Applications

Beyond aging, cortisol DHEA research has explored whether the ratio offers diagnostic or prognostic value in stress-related conditions.

Chronic Stress and Burnout

Occupational burnout is characterized by emotional exhaustion, depersonalization, and reduced personal accomplishment — and is associated with HPA axis dysregulation. Some research has proposed that burnout involves a shift from the high-cortisol stage of acute/chronic stress to a state of "adrenal fatigue" or HPA hyporesponsiveness, with relatively more preserved DHEA production.

The cortisol DHEA balance research literature on burnout suggests:

• Early burnout stages may show elevated cortisol with declining DHEA-S, producing a high ratio
• Late or severe burnout may show low cortisol alongside low DHEA-S, making ratio interpretation ambiguous
• Cross-sectional studies are difficult to interpret because they capture different stages of a dynamic process

PTSD

Post-traumatic stress disorder has been linked to HPA axis dysregulation in multiple studies, with some showing elevated cortisol reactivity and others showing blunted responses — likely reflecting heterogeneity in trauma type, duration, and time since trauma. Several cortisol DHEA clinical studies in PTSD populations have found:

• DHEA-S may be relatively preserved or elevated in some PTSD patients compared to depression
• A lower cortisol/DHEA-S ratio has been associated with symptom severity in some studies, but findings are inconsistent
• DHEA has been proposed as a potential treatment augmentation for PTSD, with preliminary positive results in some small trials

Depression and Anxiety

DHEA and cortisol have both been implicated in the pathophysiology of major depressive disorder (MDD), and the DHEA cortisol ratio has been examined as a potential depressive biomarker. Current evidence suggests:

• Elevated cortisol is more consistently associated with melancholic depression and treatment resistance
• DHEA-S is lower in some (not all) depressed populations
• The ratio has not achieved sufficient sensitivity/specificity to serve as a diagnostic marker for depression in clinical practice
• Anxiety disorders show less consistent patterns with cortisol or DHEA individually, and ratio data are sparse

Adolescent Development

The 2024 early-life stress study highlighted an important developmental angle: the DHEA cortisol ratio in adolescents may operate differently than in adults. Adolescence is a period of rapidly changing DHEA production (adrenarche begins in childhood with DHEA-S rise; puberty involves further sex steroid changes), meaning the ratio trajectory is not monotonic across development.

The finding that a lower ratio mediated externalizing problems in boys specifically points to the need for age- and sex-stratified reference ranges and interpretation frameworks — a gap the current literature has not adequately addressed.

---

Testing Methods: Saliva, Blood, or Hair?

One of the most practically important questions in DHEA cortisol balance research is which biological matrix provides the most valid and actionable cortisol DHEA biomarker measurements. The answer depends on what you are trying to measure.

Serum/Plasma Testing

Best for: Baseline DHEA-S levels, fasting morning cortisol, clinical endocrinology workups, mortality/aging research

• DHEA-S is the preferred analyte in serum because it is highly stable and measurable with standard immunoassay platforms
• Cortisol measured in serum reflects both free and protein-bound cortisol (approximately 90–95% is bound to cortisol-binding globulin and albumin)
• CBG levels can confound serum cortisol in conditions like pregnancy, liver disease, or with estrogen use
• The majority of cohort and mortality studies (including the 2010 mortality study) used serum measurements

Salivary Testing

Best for: Diurnal cortisol rhythms, cortisol awakening response, acute stress reactivity, DHEA in the free fraction

• Saliva contains predominantly free (unbound) cortisol, which is the biologically active fraction
• Salivary DHEA reflects unconjugated, free DHEA — not DHEA-S, which does not readily enter saliva
• Multiple-sample salivary protocols (e.g., 4-point or 6-point daily profiles) capture diurnal dynamics that single-point testing misses
• The 2024 academic stress study used salivary measurements, making its ratio directly comparable only to other salivary ratio studies

Hair Testing

Best for: Retrospective integrated hormone assessment (in theory)

• Hair cortisol incorporates from scalp hair follicles over approximately 1 cm per month of growth
• In theory, a 3 cm hair segment reflects 3 months of retrospective cortisol output — capturing chronic rather than acute stress exposure
• Hair DHEA is similarly measured and the ratio proposed as a chronic stress biomarker
• The 2024 systematic review found no significant association between hair cortisol/DHEA ratio and perceived stress — the single most important finding for practitioners considering this panel

Urine Testing

Best for: 24-hour integrated cortisol output, metabolomics research

• 24-hour urinary free cortisol captures integrated daily production
• Urine DHEA metabolites (DHEA, androsterone, etiocholanolone) can be measured in expanded urinary steroid profiles
• Urinary testing is less common in ratio-specific research but is used in comprehensive adrenal workups

Dried Blood Spot (DBS)

Best for: Population research, remote collection, cost-effective screening

• DBS allows home collection and mail-in testing
• Suitable for DHEA-S measurement; cortisol is measurable but more variable
• DBS-based ratio data are limited in the current literature

Practical Guidance for Interpretation

Mixing measurements from different matrices for ratio calculation is problematic. A serum cortisol/salivary DHEA ratio has no validated reference range. Always confirm that a reported ratio uses the same matrix for both analytes and that the laboratory has validated its own reference ranges for that matrix.

---

What Are Normal or Optimal Ranges?

This is one of the most common clinical questions about the DHEA cortisol ratio, and the honest answer is that there is no single universally accepted normal range. Reference intervals vary by:

• Biological matrix (saliva, serum, urine, hair)
• Age and sex of the patient
• Time of sample collection
• Laboratory-specific assay methodology
• Whether DHEA or DHEA-S is used as the denominator (or numerator, as ratio orientation varies by lab)

General Serum Reference Considerations

In serum-based research, the cortisol/DHEA-S ratio is typically expressed in nmol/nmol or after unit conversion. Some published research and commercial reference laboratories report the ratio as cortisol (nmol/L) divided by DHEA-S (μmol/L), producing a ratio value that increases as cortisol rises or DHEA-S falls.

Published reference intervals from functional medicine and integrative health contexts often suggest a morning serum cortisol/DHEA-S ratio (in compatible units) below 0.5 as favorable, with ratios above 1.0 considered elevated — but these thresholds are not derived from high-quality randomized outcome studies and should be interpreted with appropriate caution.

Age-Specific Expectations

Given that DHEA-S declines progressively with age, the "normal" ratio at age 30 is very different from normal at age 65. Using a uniform cutoff across all age groups will systematically misclassify older adults as having unfavorable ratios when their values simply reflect normal adrenopause-related DHEA-S decline. Age-stratified reference percentiles are methodologically necessary but are not yet uniformly applied across clinical laboratories.

The Salivary Ratio

For salivary testing, the ratio is typically expressed in pg/mL units for both analytes. The OAT (organic acids test) and comprehensive adrenal stress panels from various commercial laboratories each apply their own internally derived reference ranges, and these are not interchangeable between providers.

Why "Optimal" Is Not the Same as "Normal"

An important conceptual distinction in cortisol DHEA health research is the difference between population-normal and physiologically optimal. A serum DHEA-S in the bottom quartile for a 55-year-old woman may be "within normal range" for age but still represent a substantially higher cortisol/DHEA-S ratio than was present at her physiological peak. Whether restoring DHEA-S to "optimal" (rather than merely normal-for-age) improves outcomes is an unresolved research question.

---

How Reliable Is the Ratio Compared to Cortisol Alone?

The fundamental question underpinning the entire cortisol DHEA ratio research enterprise is whether the ratio adds meaningful information beyond cortisol alone.

Evidence That the Ratio Adds Value

1. The 2025 epigenetic aging study found the cortisol/DHEA-S ratio was the only hormonal measure significantly correlated with Hannum clock acceleration — cortisol alone was not significant for that clock. This is a direct demonstration of incremental validity.

1. The 2024 academic stress study found the post-examination ratio correlated more strongly with academic performance (rs = 0.44) than cortisol alone, suggesting the ratio captures performance-relevant variance that cortisol misses.

1. Theoretical arguments are compelling: because DHEA-S declines with age and stress exposure, a cortisol measurement that looks "normal" in absolute terms may reflect physiological imbalance in a patient with substantially depleted DHEA-S. The ratio contextualizes cortisol relative to the individual's adrenal reserve.

Evidence That the Ratio Has Limited Additional Value

1. The 2024 systematic review on hair measurements found no significant stress association for the ratio — and notably, the evidence base for hair cortisol alone as a stress marker is also contested, so this may reflect limitations of the hair matrix rather than the ratio concept specifically.

1. The 2025 epigenetic study found the ratio explained only 0.5%–1.1% of additional variance beyond chronological age — a statistically significant but clinically small increment.

1. Ratio calculations introduce compounded measurement error: if both cortisol and DHEA/DHEA-S are measured with 10–15% intra-individual biological variation (which they are), the ratio inherits the combined variability of both measurements. This means single-point ratio measurements have substantial noise.

1. Confounding by CBG: Since serum cortisol is predominantly bound to cortisol-binding globulin, conditions that alter CBG (pregnancy, estrogen therapy, hypothyroidism) can dramatically change measured cortisol without reflecting true physiological change, inflating or deflating the calculated ratio.

The Verdict

The weight of evidence suggests the DHEA cortisol ratio provides incremental information over cortisol alone in specific contexts — particularly aging research and acute psychosocial stress studies. However, the additional information is modest in magnitude, and the ratio inherits significant measurement variability. Using the ratio does not replace careful consideration of cortisol dynamics, and a ratio result must always be interpreted alongside absolute values of both analytes, not in isolation.

---

Is There Enough Evidence for Clinical Use?

This is the most practically consequential question in the entire cortisol DHEA clinical literature, and the answer requires careful stratification by application.

Applications With More Supportive Evidence

Research and population-level aging studies: The association between elevated cortisol/DHEA-S ratio and mortality (2010 cohort), epigenetic age acceleration (2025), and age-related health outcomes is replicated enough to justify continued research use and consideration as part of composite allostatic load batteries.

Acute stress reactivity protocols: The ratio's responsiveness to acute psychosocial stress (demonstrated in the 2024 academic stress study and consistent with earlier literature on cortisol awakening response studies) means it may add value in controlled research protocols examining stress biology.

Longitudinal monitoring in clinical research: In the context of clinical trials investigating HPA axis interventions (e.g., mind-body practices, pharmacological DHEA trials, stress management programs), the ratio provides a more comprehensive endpoint than cortisol alone.

Applications With Insufficient Evidence

Chronic stress screening in clinical practice: The 2024 systematic review's failure to find a significant association between the hair cortisol/DHEA ratio and perceived stress directly undermines this application. The authors explicitly called for standardized longitudinal studies before clinical use — a call that has not yet been adequately answered.

Burnout diagnosis: While the theoretical rationale is sound, there are no validated diagnostic cutoffs with demonstrated sensitivity and specificity for occupational burnout diagnosis using the cortisol/DHEA ratio.

Depression, anxiety, or PTSD diagnosis: The ratio is not sufficiently sensitive or specific to serve as a standalone psychiatric diagnostic biomarker.

Guiding DHEA supplementation in individual patients: Without standardized optimal-range definitions validated against clinical outcomes, using the ratio to prescribe or dose DHEA is not evidence-based.

The Standardization Problem

A recurrent theme in DHEA cortisol balance research is the absence of standardization. Different studies use different matrices, different assay platforms, different collection protocols, different ratio orientations (cortisol/DHEA vs. DHEA/cortisol), and different populations. The 2024 systematic review's call for "standardized longitudinal studies" reflects a field that has produced interesting signal but insufficient evidence infrastructure to support clinical translation.

The path to clinical adoption likely requires:

• Prospective longitudinal cohort data linking ratio trajectories to hard clinical outcomes
• Validated age- and sex-stratified reference ranges across multiple matrices
• Head-to-head comparison studies of cortisol alone versus the ratio for specific clinical decisions
• Standardized pre-analytical protocols (fasting status, time of day, exclusion criteria)

---

Key Takeaways for Clinicians and Researchers

The cortisol DHEA ratio biomarker research field has matured enough to offer several evidence-based conclusions:

What We Know With Reasonable Confidence

1. The ratio rises with age due to declining DHEA-S, and a higher ratio is associated with greater all-cause mortality risk in cohort data (2010 study).

1. The ratio responds to acute psychosocial stress in salivary testing, and the post-stress ratio may correlate with performance-relevant outcomes.

1. The cortisol/DHEA-S ratio specifically — not cortisol alone — correlated with Hannum epigenetic clock acceleration in 2025 research, suggesting unique variance capture for this specific aging measure.

1. The ratio operates differently across developmental stages and sexes — adolescent boys show opposite directional associations compared to adult "high ratio = risk" narratives.

1. Hair cortisol/DHEA ratio shows no significant association with perceived stress in meta-analytic data, making this specific application unsupported.

What Remains Unresolved

1. Optimal reference ranges by age, sex, and matrix are not established.

1. Whether the ratio predicts clinical outcomes better than cortisol alone across diverse populations is not proven.

1. Whether intervening to lower the ratio (through lifestyle, DHEA supplementation, or stress reduction) improves the clinical outcomes it predicts is largely untested in rigorous trials.

1. The mechanistic pathway linking the ratio to epigenetic aging requires further investigation.

For Clinical Practice

Clinicians ordering cortisol DHEA clinical panels should:

• Use matrix-specific, age-stratified reference ranges from their testing laboratory
• Not use a single-time-point ratio as a standalone diagnostic test
• Consider the ratio as one component of a broader hormonal and allostatic load assessment
• Be transparent with patients that this is an evolving evidence base, not a validated diagnostic standard
• Follow the research as standardization and longitudinal outcome data continue to develop

---

Frequently Asked Questions

What is the cortisol/DHEA or cortisol/DHEAS ratio?

It is a biomarker calculated by dividing a cortisol measurement by a simultaneous DHEA (unconjugated) or DHEA-S (sulfated) measurement from the same biological specimen. It aims to capture the balance between catabolic/stress signaling and anabolic/neuroprotective adrenal output.

Is a high cortisol-to-DHEA ratio bad?

In most research contexts, a higher ratio is associated with less favorable outcomes — including greater mortality risk in cohort studies and epigenetic age acceleration. However, context matters: in adolescent boys with early-life stress, a lower ratio was associated with worse behavioral outcomes, illustrating that interpretation depends on population and age.

Does the ratio reflect chronic stress or acute stress better?

It depends on the specimen. Salivary testing reflects acute-to-subacute stress (hours to days). Serum DHEA-S reflects more chronic adrenal output. Hair cortisol/DHEA theoretically reflects 1–3 months of integrated output, but meta-analytic evidence does not currently validate it as a reliable chronic stress marker.

Is saliva, blood, or hair the best specimen for testing?

There is no single "best" matrix — choice depends on what you are measuring. Serum is best for stable DHEA-S levels and is supported by the most outcome data. Saliva is best for diurnal dynamics and acute stress research. Hair is theoretically attractive for chronic stress but currently lacks validation.

Can the ratio predict aging, burnout, depression, or metabolic risk?

What are normal or optimal ranges?

There are no universally accepted normal ranges. Reference intervals vary by matrix, laboratory, assay methodology, age, and sex. Age-stratified, matrix-specific reference ranges from your testing laboratory should always be used, and "optimal" targets are not yet evidence-defined.

How reliable is the ratio compared with cortisol alone?

The ratio provides modest incremental information over cortisol alone — demonstrated specifically for the Hannum epigenetic clock and acute stress performance correlations. The additional value is real but small in magnitude, and ratio measurements compound the measurement variability of both analytes.

Is there enough evidence to use it clinically?

For research purposes and as part of composite allostatic load assessments: yes, with appropriate caveats. As a standalone clinical diagnostic tool for any specific condition: the evidence is insufficient. The 2024 systematic review explicitly concluded evidence does not yet support clinical application for chronic stress assessment, and this conclusion extends broadly across most proposed clinical uses.

---

---

References and Further Reading

1. PMC12357812 — Cortisol, DHEA-S, and cortisol/DHEA-S ratio as predictors of epigenetic aging acceleration (2025, PubMed Central)
2. OptimalDx.com — Adrenal biomarkers: cortisol to DHEA-S ratio (updated 2026)
3. PubMed PMID 40978330 — Systematic review and meta-analysis: hair cortisol and DHEA ratio as a chronic stress biomarker (2024)
4. 2024 Psychoneuroendocrinology study — Cortisol/DHEA ratio mediating early-life stress and externalizing problems in adolescent boys
5. 2024 Neuro Endocrinology Letters — Salivary cortisol/DHEA ratio and academic stress
6. 2010 cohort study — Cortisol:DHEA-S ratio and all-cause, cancer, and medical-cause mortality
7. 2025–2026 indexed article — Cortisol, DHEA-S, cortisol/DHEA-S ratio, and oxidative stress markers in Korean adults

---

This post is intended for educational and research purposes. It does not constitute medical advice. Clinicians should use clinical judgment and consult current guidelines when applying any biomarker in patient care.